REGENTS OF THE UNIVERSITY OF MINNESOTA
MINNEAPOLIS, New York
Total Received
$423.4M
Total Awards
161
State
New York
Last Updated
Mar 20, 2026
Yearly Funding Trend
$355.1M24
$67.6M25
$745K26
Top 50 Awards to REGENTS OF THE UNIVERSITY OF MINNESOTA
Largest individual federal awards on record for this recipient, ranked by obligated amount. Data through March 20, 2026.
| Award | Awarding Agency | Program | Place | FY | Obligation |
|---|---|---|---|---|---|
ASST_NON_P30CA016056_075 ROSWELL PARK CCSG ADMIN SUPPLEMENT: CLOSE OUT EDDOP STUDIES - ROSWELL PARK COMPREHENSIVE CANCER CENTER (ROSWELL PARK), ESTABLISHED IN 1898 IS ONE OF A SMALL NUMBER OF FREESTANDING… | Department of Health and Human Services National Institutes of Health | 93.397 CANCER CENTERS SUPPORT GRANTS | BUFFALO, NY-26 | 2024 | $85,009,758 |
ASST_NON_P01CA055791_075 PDT OPTIMIZATION AND MECHANISMS - DESCRIPTION (PROVIDED BY APPLICANT): HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC) IS THE 6TH MOST COMMON CANCER WORLDWIDE AND THE 8TH MOST COMM… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | BUFFALO, NY-26 | 2024 | $22,384,526 |
ASST_NON_P50CA159981_075 ROSWELL PARK OVARIAN CANCER SPORE - OVERALL SUMMARY – ROSWELL PARK-UNIVERSITY OF CHICAGO OVARIAN CANCER SPORE THIS IS THE REVISED COMPETING RENEWAL APPLICATION OF THE ROSWELL PARK… | Department of Health and Human Services National Institutes of Health | 93.397 CANCER CENTERS SUPPORT GRANTS | BUFFALO, NY-26 | 2024 | $19,571,279 |
ASST_NON_U54CA228110_075 WNY CENTER FOR RESEARCH ON FLAVORED TOBACCO PRODUCTS (CROFT) - FLAVORS INCREASINGLY DRIVE THE USE OF EMERGING TOBACCO PRODUCTS (CIGARILLOS, WATERPIPE, ELECTRONIC NICOTINE DELIVERY… | Department of Health and Human Services National Institutes of Health | 93.077 FAMILY SMOKING PREVENTION AND TOBACCO CONTROL ACT REGULATORY RESEARCH | BUFFALO, NY-26 | 2025 | $19,490,160 |
ASST_NON_P01CA234212_075 TARGETING THE CHEMOKINE SYSTEM TO SENSITIZE TUMORS TO IMMUNOTHERAPY - THE REVISED P01CA234212 TESTS NOVEL STRATEGIES TO PROMOTE SELECTIVE CTL ENTRY INTO TUMOR MICRO- ENVIRONMENTS… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | BUFFALO, NY-26 | 2024 | $10,113,383 |
ASST_NON_R35CA197616_075 ADVANCING CANCER THERAPY THROUGH GROUNDBREAKING RESEARCH IN RADIATION BIOLOGY - PROJECT SUMMARY/ABSTRACT RADIATION THERAPY IS UTILIZED TO TREAT APPROXIMATELY HALF OF ALL CANCER PA… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | BUFFALO, NY-26 | 2024 | $9,816,869 |
ASST_NON_U24CA232979_075 IMMUNO-ONCOLOGY TRANSLATION NETWORK: DATA MANAGEMENT AND RESOURCE-SHARING CENTER AT RPCI - PROJECT SUMMARY WHILE SEVERAL INNOVATIVE AND CREATIVE IMMUNO-ONCOLOGY (IO) STRATEGIES HA… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | BUFFALO, NY-26 | 2024 | $8,764,855 |
ASST_NON_C06OD037775_075 ONE BIOREPOSITORY: COMPREHENSIVE INTEGRATED BIOBANKING SYSTEMS - PROJECT SUMMARY/ABSTRACT. AS A COMPREHENSIVE CANCER CENTER WITH A MISSION TO `UNDERSTAND, PREVENT AND CURE CANCER'… | Department of Health and Human Services National Institutes of Health | 93.352 CONSTRUCTION SUPPORT | BUFFALO, NY-26 | 2024 | $7,731,872 |
ASST_NON_UH3CA260602_075 DISPARITIES IN RESULTS OF IMMUNE CHECKPOINT INHIBITOR TREATMENT (DIRECT): A PROSPECTIVE COHORT STUDY OF CANCER SURVIVORS TREATED WITH ANTI-PD-1/ANTI-PD-L1 IN A COMMUNITY ONCOLOGY… | Department of Health and Human Services National Institutes of Health | 93.393 CANCER CAUSE AND PREVENTION RESEARCH | BUFFALO, NY-26 | 2024 | $7,225,267 |
ASST_NON_U24CA274159_075 COORDINATING AND DATA MANAGEMENT CENTER FOR ACQUIRED RESISTANCE TO THERAPY NETWORK - PROJECT SUMMARY THE GOAL OF OUR PROPOSED COORDINATING AND DATA MANAGEMENT CENTER (CDMC) APPLIC… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | BUFFALO, NY-26 | 2024 | $6,584,333 |
ASST_NON_R01CA257480_075 TRANSCRIPTOMIC CLASSIFICATION OF NON-MUSCLE INVASIVE BLADDER CANCER AND ITS CLINICAL AND PROGNOSTIC IMPLICATION - THIS STUDY ADDRESSES THE UNMET CLINICAL NEEDS FOR MANAGEMENT OF N… | Department of Health and Human Services National Institutes of Health | 93.393 CANCER CAUSE AND PREVENTION RESEARCH | BUFFALO, NY-26 | 2024 | $6,547,653 |
ASST_NON_R01CA228156_075 SOMATIC MUTATIONS AND THEIR ETIOLOGICAL DETERMINANTS FOR BREAST CANCER IN AFRICAN AMERICAN WOMEN - PROJECT SUMMARY/ ABSTRACT. THE BREAST CANCER HEALTH DISPARITY BETWEEN WOMEN OF A… | Department of Health and Human Services National Institutes of Health | 93.393 CANCER CAUSE AND PREVENTION RESEARCH | BUFFALO, NY-26 | 2025 | $6,510,127 |
ASST_NON_W81XWH1910674_097 NOVEL IMMUNOTHERAPY FOR BRAIN-METASTATIC BREAST CANCER | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | BUFFALO, NY-26 | 2024 | $6,420,739 |
ASST_NON_R01CA130995_075 REPLICATION LICENSING IN GENOME STABILITY, CANCER AND AGING - ABSTRACT THIS PROPOSAL ADDRESSES BASIC MECHANISMS BY WHICH DNA REPLICATION ORIGIN FUNCTION MAINTAINS GENOME STABILITY… | Department of Health and Human Services National Institutes of Health | 93.393 CANCER CAUSE AND PREVENTION RESEARCH | BUFFALO, NY-26 | 2025 | $5,257,484 |
ASST_NON_R01CA247281_075 TUMOR IMMUNE CONTEXTURE AND BREAST CANCER DISPARITIES: A MULTI-DISCIPLINARY STUDY IN WOMEN OF AFRICAN AND EUROPEAN ANCESTRY - ABSTRACT. BREAST CANCER RATES IN AMERICAN WOMEN OF AF… | Department of Health and Human Services National Institutes of Health | 93.393 CANCER CAUSE AND PREVENTION RESEARCH | BUFFALO, NY-26 | 2024 | $5,176,536 |
ASST_NON_R01AI140736_075 ST6GAL-1 SIALYLTRANSFERASE IN INFLAMMATION - PROJECT ABSTRACT THERE IS INCREASING AWARENESS OF GLYCANS PARTICIPATING IN THE COMMUNICATION OF CRITICAL NICHE-CELL AND CELL-CELL INFO… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | BUFFALO, NY-26 | 2024 | $3,877,254 |
ASST_NON_R01CA258337_075 BEHAVIORAL PARENTING SKILLS AS A NOVEL TARGET FOR IMPROVING PEDIATRIC MEDICATION ADHERENCE - IN PEDIATRIC HEALTH CARE NON-ADHERENCE TO MEDICATIONS IS A SIGNIFICANT DRIVER OF AVOID… | Department of Health and Human Services National Institutes of Health | 93.393 CANCER CAUSE AND PREVENTION RESEARCH | BUFFALO, NY-26 | 2024 | $3,527,155 |
ASST_NON_R01CA250412_075 IMPACT OF CIRCULATING MYELOID CELL CLUSTERS ON ANTI-TUMOR IMMUNITY - DURABLE OUTCOMES IN SUBSETS OF SOLID CANCER PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS (ICI) OR ADOPTI… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | BUFFALO, NY-26 | 2024 | $3,445,316 |
ASST_NON_R01CA255515_075 METFORMIN FOR CHEMOPREVENTION OF LUNG CANCER IN OBESE SUBJECTS AT HIGH RISK - PROJECT SUMMARY DESPITE ADVANCES IN TREATMENT, SUCH AS TARGETED AND IMMUNE THERAPIES, LUNG CANCER REM… | Department of Health and Human Services National Institutes of Health | 93.393 CANCER CAUSE AND PREVENTION RESEARCH | BUFFALO, NY-26 | 2024 | $3,423,650 |
ASST_NON_R01CA188900_075 A CRISPR-BASED PLATFORM FOR TESTING NEUTROPHIL RESPONSES IN THE OVARIAN CANCER MICROENVIRONMENT - ABSTRACT THIS APPLICATION IS BEING SUBMITTED IN RESPONSE TO NOT-CA-19-028. OUR GO… | Department of Health and Human Services National Institutes of Health | 93.353 21ST CENTURY CURES ACT - BEAU BIDEN CANCER MOONSHOT | BUFFALO, NY-26 | 2024 | $3,303,521 |
ASST_NON_U01CA256801_075 OPTIMIZING DUAL-TARGETED AND DUAL-ARMORED CAR T CELLS FOR SMALL CELL LUNGCANCER - ABSTRACT A PATIENT'S OWN T CELLS CAN BE MODIFIED USING GENE THERAPY TECHNOLOGY TO EXPRESS RECEPTO… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | BUFFALO, NY-26 | 2024 | $3,246,184 |
ASST_NON_R01CA255242_075 ADVANCING SKIN CANCER PREVENTION BY TACKLING UV-INDUCED CLONOGENIC MUTATIONS - 1 SQUAMOUS CELL SKIN CANCER (SCC) IS THE SECOND MOST COMMON CANCER IN THE US. THERE ARE METHODS AVAI… | Department of Health and Human Services National Institutes of Health | 93.394 CANCER DETECTION AND DIAGNOSIS RESEARCH | BUFFALO, NY-26 | 2024 | $3,218,488 |
ASST_NON_R01CA225947_075 RELATIONSHIPS BETWEEN PARITY, BREASTFEEDING AND ER- BREAST CANCER IN AFRICAN AMERICAN WOMEN: ELUCIDATING THE BIOLOGIC UNDERPINNINGS AT THE MOLECULAR AND CELLULAR LEVEL. - ABSTRACT… | Department of Health and Human Services National Institutes of Health | 93.393 CANCER CAUSE AND PREVENTION RESEARCH | BUFFALO, NY-26 | 2025 | $3,161,937 |
ASST_NON_R01CA247362_075 RB TUMOR SUPPRESSOR AS A THERAPEUTIC TARGET IN ER-POSITIVE BREAST CANCER - ABSTRACT: OUR WORK OVER THE LAST SEVERAL YEARS, INDICATES THAT CELL CYCLE REGULATORY PATHWAYS ARE CRITIC… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | BUFFALO, NY-26 | 2024 | $3,127,879 |
ASST_NON_R01CA262899_075 MULTI-ETHNIC HIGH-THROUGHPUT STUDY TO IDENTIFY NOVEL NON-HLA GENETIC CONTRIBUTORS TO MORTALITY AFTER BLOOD AND MARROW TRANSPLANTATION - PROJECT SUMMARY BLOOD AND MARROW TRANSPLANT… | Department of Health and Human Services National Institutes of Health | 93.393 CANCER CAUSE AND PREVENTION RESEARCH | BUFFALO, NY-26 | 2024 | $3,120,296 |
ASST_NON_UG1CA233191_075 NETWORK LEAD ACADEMIC PARTICIPATING SITE GRANT FROM THE ROSWELL PARK CANCER INSTITUTE - PROJECT SUMMARY THE ROSWELL PARK CANCER INSTITUTE HAS HAD A LONG TRADITION OF CONTRIBUTING… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | BUFFALO, NY-26 | 2024 | $3,055,842 |
ASST_NON_R25CA181003_075 SUMMER RESEARCH EXPERIENCES IN CANCER SCIENCE AND ONCOLOGY - PROJECT SUMMARY/ABSTRACT FOR A STUDENT DECIDING ON HIS OR HER FUTURE CAREER OR SPECIALTY, A MENTORED RESEARCH EXPERIEN… | Department of Health and Human Services National Institutes of Health | 93.398 CANCER RESEARCH MANPOWER | BUFFALO, NY-26 | 2025 | $3,032,041 |
ASST_NON_R01CA222382_075 PREOPERATIVE RESPIRATORY MUSCLE TRAINING TO PREVENT POSTOPERATIVE PULMONARY COMPLICATIONS IN PATIENTS UNDERGOING RESECTION FOR LUNG CANCER - PROJECT SUMMARY/ABSTRACT SURGICAL RESE… | Department of Health and Human Services National Institutes of Health | 93.394 CANCER DETECTION AND DIAGNOSIS RESEARCH | BUFFALO, NY-26 | 2025 | $3,008,512 |
ASST_NON_R01CA234162_075 NOTCH SIGNALING CONTROLS TRANSFORMATION TO ANDROGEN INDEPENDENT NEUROENDOCRINE PROSTATE CANCER - ANDROGEN DEPRIVATION THERAPY (ADT) IS EFFECTIVE IN TREATING METASTATIC PROSTATE AD… | Department of Health and Human Services National Institutes of Health | 93.393 CANCER CAUSE AND PREVENTION RESEARCH | BUFFALO, NY-26 | 2024 | $3,003,237 |
ASST_NON_R01ES034250_075 STAG2 MODULATES ENVIRONMENTAL TOXICANT EXPOSURES AND EPIGENOMIC HETEROGENEITY - ABSTRACT EPIDEMIOLOGICAL EVIDENCE SUGGESTS THAT ENVIRONMENTAL EXPOSURES DURING DEVELOPMENT MAY PLAY… | Department of Health and Human Services National Institutes of Health | 93.113 ENVIRONMENTAL HEALTH | BUFFALO, NY-26 | 2024 | $2,986,065 |
ASST_NON_R01CA229415_075 ENHANCING RELAPSE PREVENTION WITH RTMS: DOSE-RESPONSE PARAMETERS FOR SMOKING CESSATION - PROJECT SUMMARY / ABSTRACT. TOBACCO USE REMAINS A SIGNIFICANT CAUSE OF DEATH AND DISEASE.… | Department of Health and Human Services National Institutes of Health | 93.393 CANCER CAUSE AND PREVENTION RESEARCH | BUFFALO, NY-26 | 2024 | $2,950,485 |
ASST_NON_R01CA243456_075 RADIOGENOMIC CREDENTIALING OF HEAD AND NECK CANCER MODELS - ABSTRACT HEAD AND NECK SQUAMOUS CELL CARCINOMAS (HNSCC) ARE AGGRESSIVE NEOPLASMS THAT RESULT IN DEBILITATING CHANGES IN… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | BUFFALO, NY-26 | 2024 | $2,932,365 |
ASST_NON_R01CA251545_075 FUNCTIONAL SIGNIFICANCE OF INDIVIDUAL P53 MUTATIONS IN DETERMINING THE ROLE OF ESTROGEN RECEPTOR BETA IN TRIPLE NEGATIVE BREAST CANCER - TRIPLE NEGATIVE BREAST CANCERS (TNBCS) DO… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | BUFFALO, NY-26 | 2024 | $2,894,996 |
ASST_NON_R01CA207540_075 THE INFLUENCE OF SOCIAL NETWORK SIZE, COMPOSITION AND FUNCTION ON PSYCHOLOGICAL OUTCOMES OF PEDIATRIC CANCER CAREGIVING: RELATIONSHIPS ACROSS TIME AND AROUND PERIODS OF DISTRESS -… | Department of Health and Human Services National Institutes of Health | 93.393 CANCER CAUSE AND PREVENTION RESEARCH | BUFFALO, NY-26 | 2024 | $2,865,363 |
ASST_NON_R01HD109750_075 GENERATION AND ANALYSIS OF NEW MOUSE MODELS TO DETERMINE NOVEL THERAPEUTIC TARGETS FOR DOWN SYNDROME-ASSOCIATED COGNITIVE DEFICITS - IN THE UNITED STATES, DOWN SYNDROME OCCURS IN… | Department of Health and Human Services National Institutes of Health | 93.310 TRANS-NIH RESEARCH SUPPORT | BUFFALO, NY-26 | 2024 | $2,832,381 |
ASST_NON_R01CA205246_075 UNDERSTANDING HOW ADRENERGIC SIGNALING INFLUENCES IMMUNE CONTEXTURE OF TUMORS AND THE EFFICACY OF CHECKPOINT INHIBITORS - PROJECT SUMMARY-ABSTRACT IN NEW DATA PRESENTED IN THIS P… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | BUFFALO, NY-26 | 2024 | $2,799,968 |
ASST_NON_R01CA236390_075 TARGETING ADRENERGIC STRESS PATHWAYS TO INCREASE TUMOR SENSITIVITY TO RADIATION AND PROMOTE DEVELOPMENT OF AN ANTI-TUMOR IMMUNE RESPONSE - OUR DATA REVEAL A CRITICAL AND LARGELY U… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | BUFFALO, NY-26 | 2025 | $2,794,767 |
ASST_NON_R01DA057228_075 ASSESSING PHARMACOKINETIC AND PHARMACODYNAMIC VARIABILITY OF Δ9-TETRAHYDROCANNABINOL DELIVERED FROM VAPING PRODUCTS WITH AND WITHOUT CONCURRENT USE OF NICOTINE - PROJECT SUMMARY T… | Department of Health and Human Services National Institutes of Health | 93.279 DRUG USE AND ADDICTION RESEARCH PROGRAMS | BUFFALO, NY-26 | 2024 | $2,720,537 |
ASST_NON_R01MD016850_075 IMPLEMENTATION OF EVIDENCE-BASED STRATEGIES TO OPTIMIZE HPV VACCINATION IN RURAL PRIMARY CARE SETTINGS - ABSTRACT SOME OF THE LARGEST DISPARITIES IN HUMAN PAPILLOMAVIRUS VACCINATI… | Department of Health and Human Services National Institutes of Health | 93.307 MINORITY HEALTH AND HEALTH DISPARITIES RESEARCH | BUFFALO, NY-26 | 2024 | $2,685,848 |
ASST_NON_R01CA240290_075 NOVEL THERAPEUTIC STRATEGIES TO CO-TARGET UNDIFFERENTIATED PROSTATE CANCER (PCA) STEM CELLS AND BULK PCA CELLS - CASTRATION-RESISTANT PROSTATE CANCER (CRPC) KILLS ~28,000 AMERICAN… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | BUFFALO, NY-26 | 2025 | $2,637,993 |
ASST_NON_R01CA267690_075 TARGETING COMPLEMENT TO ENHANCE ANTITUMOR IMMUNITY AND CONTROL MALIGNANT EFFUSIONS IN PATIENTS WITH RECURRENT EPITHELIAL OVARIAN CANCER - ABSTRACT EPITHELIAL OVARIAN CANCER (OC) I… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | BUFFALO, NY-26 | 2024 | $2,601,255 |
ASST_NON_R50CA211108_075 ASSOCIATE-DIRECTOR FLOW AND IMAGE CYTOMETRY ROSWELL PARK COMPREHENSIVECANCER CENTER - THE CURRENT APPLICATION SEEKS CONTINUED SALARY SUPPORT FOR HANS MINDERMAN, PHD WHO SERVES AS… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | BUFFALO, NY-26 | 2024 | $2,591,979 |
ASST_NON_R01AI155499_075 UNDERSTANDING MECHANISMS AND CONSEQUENCES OF T CELL CO-RECEPTOR REGULATED RNA MATURATION - PROJECT ABSTRACT/SUMMARY. T CELLS ARE UNIQUE IN THEIR REQUIREMENT FOR TWO ACTIVATION SIG… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | BUFFALO, NY-26 | 2024 | $2,586,142 |
ASST_NON_DP2CA260421_075 DECODING THE NUCLEAR METABOLIC PROCESSES REGULATING GENE TRANSCRIPTION - IN THIS HIGH RISK HIGH REWARD DP2 APPLICATION I WISH TO INVESTIGATE THE NUCLEAR FUNCTIONS OF MITOCHONDRIAL… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | BUFFALO, NY-26 | 2024 | $2,526,967 |
ASST_NON_R01CA193610_075 INTEGRATED IMAGE-GUIDED DOSIMETRY AND TREATMENT PLANNING FOR PHOTODYNAMIC THERAPY - DESCRIPTION (PROVIDED BY APPLICANT): THIS RESEARCH PROPOSAL AIMS AT IMPROVING INTERSTITIA… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | BUFFALO, NY-26 | 2024 | $2,393,799 |
ASST_NON_R01CA281862_075 A MULTI-INSTITUTE SURVIVORSHIP STUDY OF PATIENTS LIVING WITH ADVANCED CANCER WHO HAVE HAD DURABLE RESPONSE TO IMMUNE CHECKPOINT INHIBITORS - ABSTRACT IMMUNE CHECKPOINT INHIBITORS… | Department of Health and Human Services National Institutes of Health | 93.393 CANCER CAUSE AND PREVENTION RESEARCH | BUFFALO, NY-26 | 2024 | $2,317,650 |
ASST_NON_T32CA085183_075 MULTIDISCIPLINARY APPROACHES TO TUMOR IMMUNOLOGY - PROJECT SUMMARY/ABSTRACT THE OVERARCHING GOALS OF THE TUMOR IMMUNOLOGY TRAINING PROGRAM (TITP) AT ROSWELL PARK COMPREHENSIVE CAN… | Department of Health and Human Services National Institutes of Health | 93.398 CANCER RESEARCH MANPOWER | BUFFALO, NY-26 | 2024 | $2,208,085 |
ASST_NON_R01CA246437_075 HSP60 REGULATION OF PROSTATE CANCER PROGRESSION - MITOCHONDRIAL PROTEIN HOMEOSTASIS (PROTEOSTASIS) HAS BEEN IMPLICATED IN CANCER AND IS REGULATED BY MITOCHONDRIAL UNFOLDED PROTEIN… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | BUFFALO, NY-26 | 2024 | $2,185,351 |
ASST_NON_R01CA262822_075 ROLE OF TYPE 2 IMMUNE RESPONSE IN PANCREATIC CANCER TUMORIGENESIS - PROJECT SUMMARY: PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) IS AN AGGRESSIVE DISEASE THAT REMAINS LARGELY INCURABL… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | BUFFALO, NY-26 | 2024 | $2,165,563 |
ASST_NON_R01HL167232_075 TARGETING CD83 TO REDUCE LEUKEMIA RELAPSE AND GVHD AFTER ALLOGENEICHEMATOPOIETIC CELL TRANSPLANTATION - PROJECT SUMMARY POST-TRANSPLANT CYCLOPHOSPHAMIDE (PTCY) HAS SUBSTANTIALLY R… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | MINNEAPOLIS, MN-05 | 2024 | $2,162,546 |
Top 50 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Federal Programs (CFDA)
View All→12345678910
93.397 — CANCER CENTERS SUPPORT GRANTS$104.6M
93.395 — CANCER TREATMENT RESEARCH$86.1M
93.393 — CANCER CAUSE AND PREVENTION RESEARCH$62.6M
93.396 — CANCER BIOLOGY RESEARCH$55.2M
12.420 — MILITARY MEDICAL RESEARCH AND DEVELOPMENT$27.1M
93.077 — FAMILY SMOKING PREVENTION AND TOBACCO CONTROL ACT REGULATORY RESEARCH$22.7M
93.398 — CANCER RESEARCH MANPOWER$9.0M
93.394 — CANCER DETECTION AND DIAGNOSIS RESEARCH$8.9M
93.352 — CONSTRUCTION SUPPORT$7.7M
93.855 — ALLERGY AND INFECTIOUS DISEASES RESEARCH$6.5M
Source: USAspending.gov · All Recipients · New York